• Ourofino’s consolidated net income rose 18% year over year to BRL 64.71 million in the quarter ended September 30, 2026.
• Quarterly net sales climbed 20% year over year to BRL 429.32 million.
• Net cash generated by operating activities increased year over year to BRL 167.43 million for the nine months ended September 30, 2026.
• Nine-month intangible asset provisions and write-offs totaled BRL 25.57 million for projects discontinued or postponed following management’s review of strategic priorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ourofino Saúde Animal Participações SA published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.